Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Oilgohydramnios
Interventions
DRUG

anti oxidant omega 3

"Soft gelatineous capsule (Sedico medical company) each capsule contains:~* Fish oil (30) % (Eicosapentaenoic acid (EPA) 18 % / Docosahexaenoic acid (DHA) 12 % ) natural source of Omega 3 Fatty acids.~* Wheat germ oil (Tocopherol: N.N.T. 0.22 %) which is rich and natural source of Vitamin E (protects the oils from oxidation. besides its well known that requirements of vitamin E increases with increased dietary amounts of polyunsaturated fatty acids).~Group 1 was given omega -3 plus (Sedico medical company) as antioxidant once daily for two weeks."

Trial Locations (1)

Unknown

Women's Health Hospital, Asyut

All Listed Sponsors
lead

Woman's Health University Hospital, Egypt

OTHER

NCT01990690 - Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial | Biotech Hunter | Biotech Hunter